Xolair 150 MG/ML autoinjectorml

Ended Awarded

Contract number
SPE2DX24FUKHP
Awardee
Awarding agency
Obligated
$5,993

Award facts

Contract value 100% obligated
$5,992.77 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

This is a $5,992.77 firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA) under the DLA's Medical Supply Chain program. The order is for the pharmaceutical product Xolair 150 mg/ml autoinjector, with a performance period through May 30, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract with the DLA under the SPE2DB program to provide a comprehensive range of pharmaceutical products to support military medical facilities worldwide. This delivery order does not have a set-aside designation.

Quick answers

Who was awarded contract SPE2DX24FUKHP?

SPE2DX24FUKHP was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on May 8, 2024.

How much is contract SPE2DX24FUKHP worth?

The government has obligated $5,993 on SPE2DX24FUKHP.

Is contract SPE2DX24FUKHP an order under another contract?

Yes. SPE2DX24FUKHP is a delivery order under SPE2DX15D9223, an indefinite delivery contract.

Was contract SPE2DX24FUKHP competed?

The extent of competition for SPE2DX24FUKHP was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award